| NCT ID | NCT05728580 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Beijing Friendship Hospital |
| Condition | Cardiovascular Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2017-12-31 |
| Primary Completion | 2022-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2017-12-31 with a primary completion date of 2022-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to discover the potential risk factors related percutaneous coronary intervention. It aims to stratify the risk of PCI patients and discover the prognostic value of these risk fators.
Eligibility Criteria
Inclusion Criteria: * Age greater than or equal to 18 years at the time of admission to the hospital * PCI patients with coronary heart disease: according to the criteria interpreted in the 2011 American Guidelines for Percutaneous Coronary Intervention. The successful diagnostic criteria of PCI: residual stenosis of the treated vessel\<10% (preferably 0%), and the forward flow is TIMI grade 3, there is no dissection that affects the flow, no important side branch occlusion, no visible thrombus and peripheral embolism. Exclusion Criteria: * Patients who failed in PCI treatment; * Current known inability to follow instructions or comply with follow-up procedures.
Contact & Investigator
Hongwei Li, Dr
STUDY DIRECTOR
Beijing Friendship Hospital
Frequently Asked Questions
Who can join the NCT05728580 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cardiovascular Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05728580 currently recruiting?
Yes, NCT05728580 is actively recruiting participants. Contact the research team at 1017120710@qq.com for enrollment information.
Where is the NCT05728580 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT05728580 clinical trial?
NCT05728580 is sponsored by Beijing Friendship Hospital. The principal investigator is Hongwei Li, Dr at Beijing Friendship Hospital. The trial plans to enroll 10,000 participants.